Deciphera Pharmaceuticals (DCPH) Tops Q3 EPS by 3c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q3 EPS of ($0.58), $0.03 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $43.31 million versus the consensus estimate of $39.44 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• Paychex beats fourth quarter EPS estimates, stock slides
• Benchmark Reiterates Hold Rating on Old Dominion Freight Line (ODFL) as 'Quality Largely Priced in'